IBM Watson Health

Decisions made when  designing a  clinical trial protocol  can have significant  downstream  financial impacts during product development and commercialization. These critical study design decisions can influence clinical trial performance in many ways, including the  quantity  of  protocol amendments,  ability to recruit  and retain  patients,  and the overall  timeline  of the development program. Fortunately, with  access to the right data,  decision making during protocol authoring can  now be  insights-driven  instead of high-risk predictions.   In this session, industry experts will discuss the challenges encountered in study design and protocol development  while  presenting concrete approaches and strategies to minimize risks,  improve decision-making, and get the protocol design right the first time.
https://vshow.on24.com/vshow/WatsonHealth2020/content/2427835
Clinical development
Webinar